Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria (original) (raw)

• Hayashi, H., Takahashi, R., Nishi, T., Sakamoto, M. & Benno, Y. Molecular analysis of jejunal, ileal, caecal and recto-sigmoidal human colonic microbiota using 16S rRNA gene libraries and terminal restriction fragment length polymorphism. J. Med. Microbiol. 54, 1093–1101 (2005).
  Article CAS PubMed Google Scholar
• Lavelle, E. C. & O'Hagan, D. T. Delivery systems and adjuvants for oral vaccines. Expert Opin. Drug Deliv. 3, 747–762 (2006).
  Article CAS PubMed Google Scholar
• Malik, D. K., Baboota, S., Ahuja, A., Hasan, S. & Ali, J. Recent advances in protein and peptide drug delivery systems. Curr. Drug Deliv. 4, 141–151 (2007).
  Article CAS PubMed Google Scholar
• Wernerus, H. & Stahl, S. Biotechnological applications for surface-engineered bacteria. Biotechnol. Appl. Biochem. 40, 209–228 (2004).
  Article CAS PubMed Google Scholar
• Uyen, N. Q., Hong, H. A. & Cutting, S. M. Enhanced immunisation and expression strategies using bacterial spores as heat-stable vaccine delivery vehicles. Vaccine 25, 356–365 (2007).
  Article CAS PubMed Google Scholar
• Pozzi, G., Oggioni, M. R. & Medaglini, D. in Gram-positive bacteria as vaccine vehicles for mucosal immunisation (eds Pozzi, G. & Wells, J. M.) 35–60 (Landes, Austin, 1997).
  Book Google Scholar
• Foligne, B. et al. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein Gastroenterology 133, 862–874 (2007). Demonstrated a new strategy for the treatment of colitis in mice based on LAB delivery of an anti-inflammatory protein that was derived from a pathogen.
  Article CAS PubMed Google Scholar
• Frossard, C. P., Steidler, L. & Eigenmann, P. A. Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization. J. Allergy Clin. Immunol. 119, 952–959 (2007).
  Article CAS PubMed Google Scholar
• Hanniffy, S. B., Carter, A. T., Hitchin, E. & Wells, J. M. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection. J. Infect. Dis. 195, 185–193 (2007). Demonstrated that intranasal vaccination with the LAB vaccine provides better protection than purified antigen against respiratory infection with virulent pneumococci. Also showed that the killed LAB vaccine protects against infection.
  Article CAS PubMed Google Scholar
• Cortes-Perez, N. G. et al. Intranasal coadministration of live lactococci producing interleukin-12 and a major cow's milk allergen inhibits allergic reaction in mice. Clin. Vaccine Immunol. 14, 226–233 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Braat, H. et al. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin. Gastroenterol. Hepatol. 4, 754–759 (2006). First clinical trial to use recombinant LAB. Demonstrated that the containment strategy for L. lactis that expresses recombinant IL-10 is effective and also that mucosal delivery of IL-10 by L. lactis is feasible in humans.
  Article CAS PubMed Google Scholar
• Neutra, M. R. & Kozlowski, P. A. Mucosal vaccines: the promise and the challenge. Nature Rev. Immunol. 6, 148–158 (2006).
  Article CAS Google Scholar
• Roland, K. L., Tinge, S. A., Killeen, K. P. & Kochi, S. K. Recent advances in the development of live, attenuated bacterial vectors. Curr. Opin. Mol. Ther. 7, 62–72 (2005).
  CAS PubMed Google Scholar
• Daudel, D., Weidinger, G. & Spreng, S. Use of attenuated bacteria as delivery vectors for DNA vaccines. Expert Rev. Vaccines 6, 97–110 (2007).
  Article CAS PubMed Google Scholar
• Tacket, C. O. & Levine, M. M. CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression. Clin. Infect. Dis. 45, S20–S23 (2007).
  Article CAS PubMed Google Scholar
• Mannam, P., Jones, K. F. & Geller, B. L. Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes. Infect. Immun. 72, 3444–3450 (2004). Demonstrated that an L. lactis vaccine which expresses the conserved C-repeat region of S. pyogenes M protein can protect mice against pharyngeal infection.
  Article CAS PubMed PubMed Central Google Scholar
• Gilbert, C., Robinson, K., Le Page, R. W. & Wells, J. M. Heterologous expression of an immunogenic pneumococcal type 3 capsular polysaccharide in Lactococcus lactis. Infect. Immun. 68, 3251–3260 (2000). Demonstrated that expression of an operon which contains 3 of the 4 genes that are required for pneumococcal type 3 capsular-polysaccharide biosynthesis in L. lactis resulted in the production of 120 mg per litre of an immunogenic capsular polysaccharide.
  Article CAS PubMed PubMed Central Google Scholar
• Mowat, A. M., Millington, O. R. & Chirdo, F. G. Anatomical and cellular basis of immunity and tolerance in the intestine. J. Pediatr. Gastroenterol. Nutr. 39, S723–S724 (2004).
  Article PubMed Google Scholar
• Rescigno, M. et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nature Immunol. 2, 361–367 (2001).
  Article CAS Google Scholar
• Chieppa, M., Rescigno, M., Huang, A. Y. & Germain, R. N. Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J. Exp. Med. 203, 2841–2852 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Macpherson, A. J. & Uhr, T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303, 1662–1665 (2004). Showed that the intragastric administration of GFP-expressing E. cloacae , a mouse commensal, results in the uptake of these bacteria by DCs in the Peyer's patches, and that these DCs traffic to the mesenteric lymph nodes.
  Article CAS PubMed Google Scholar
• Macpherson, A. J. IgA adaptation to the presence of commensal bacteria in the intestine. Curr. Top. Microbiol. Immunol. 308, 117–136 (2006).
  CAS PubMed Google Scholar
• Klijn, N., Weerkamp, A. H. & de Vos, W. M. Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract. Appl. Environ. Microbiol. 61, 2771–2774 (1995).
  CAS PubMed PubMed Central Google Scholar
• Vesa, T., Pochart, P. & Marteau, P. Pharmacokinetics of Lactobacillus plantarum NCIMB 8826, Lactobacillus fermentum KLD, and Lactococcus lactis MG 1363 in the human gastrointestinal tract. Aliment. Pharmacol. Ther. 14, 823–828 (2000).
  Article CAS PubMed Google Scholar
• Alander, M. et al. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl. Environ. Microbiol. 65, 351–354 (1999).
  CAS PubMed PubMed Central Google Scholar
• van der Waaij, L. A. et al. Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: commensal bacteria live in suspension and have no direct contact with epithelial cells. Inflamm. Bowel Dis. 11, 865–871 (2005).
  Article PubMed Google Scholar
• Valeur, N., Engel, P., Carbajal, N., Connolly, E. & Ladefoged, K. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl. Environ. Microbiol. 70, 1176–1181 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Vinderola, C. G., Medici, M. & Perdigon, G. Relationship between interaction sites in the gut, hydrophobicity, mucosal immunomodulating capacities and cell wall protein profiles in indigenous and exogenous bacteria. J. Appl. Microbiol. 96, 230–243 (2004).
  Article CAS PubMed Google Scholar
• Nouaille, S. et al. Heterologous protein production and delivery systems for Lactococcus lactis. Genet. Mol. Res. 2, 102–111 (2003).
  PubMed Google Scholar
• de Vos, W. M. Gene expression systems for lactic acid bacteria. Curr. Opin. Microbiol. 2, 289–295 (1999).
  Article CAS PubMed Google Scholar
• Mercenier, A., Muller-Alouf, H. & Grangette, C. Lactic acid bacteria as live vaccines. Curr. Issues Mol. Biol. 2, 17–25 (2000).
  CAS PubMed Google Scholar
• Norton, P. M. et al. Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis. FEMS Immunol. Med. Microbiol. 14, 167–177 (1996).
  Article CAS PubMed Google Scholar
• Hanniffy, S. et al. Potential and opportunities for use of recombinant lactic acid bacteria in human health. Adv. Appl. Microbiol. 56, 1–64 (2004).
  Article PubMed Google Scholar
• Robinson, K., Chamberlain, L. M., Schofield, K. M., Wells, J. M. & Le Page, R. W. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nature Biotechnol. 15, 653–657 (1997). In this study, mice that were orally and intranasally administered with L. lactis that expresses tetanus toxin fragment C antigen were protected from lethal systemic challenge with a 20 LD50 dose of tetanus toxin. Crucially, the killed LAB vaccine was shown to be just as immunogenic as the live LAB vaccine by the intranasal route, and tetanus toxin fragment C-specific IgA responses were elicited by the LAB vaccine.
  Article CAS Google Scholar
• Norton, P. M., Wells, J. M., Brown, H. W., Macpherson, A. M. & Le Page, R. W. Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C. Vaccine 15, 616–619 (1997).
  Article CAS PubMed Google Scholar
• Grangette, C. et al. Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum. Infect. Immun. 69, 1547–1553 (2001). Demonstrated that serum titres to TTFC are dependent on the amount of antigen that is produced by recombinant L. plantarum.
  Article CAS PubMed PubMed Central Google Scholar
• Grangette, C. et al. Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence. Vaccine 20, 3304–3309 (2002).
  Article CAS PubMed Google Scholar
• Shaw, D. M. et al. Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli. Immunology 100, 510–518 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Grangette, C. et al. Enhanced mucosal delivery of antigen with cell wall mutants of lactic acid bacteria. Infect. Immun. 72, 2731–2737 (2004). Showed that the immunogenicity of TTFC could be substantially improved by using alanine racemase mutants of L. plantarum.
  Article CAS PubMed PubMed Central Google Scholar
• Lee, M. H., Roussel, Y., Wilks, M. & Tabaqchali, S. Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice. Vaccine 19, 3927–3935 (2001).
  Article CAS PubMed Google Scholar
• Dieye, Y. et al. Ability of Lactococcus lactis to export viral capsid antigens: a crucial step for development of live vaccines. Appl. Environ. Microbiol. 69, 7281–7288 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Bermudez-Humaran, L. G. et al. An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci. J. Med. Microbiol. 53, 427–433 (2004).
  Article CAS PubMed Google Scholar
• Robinson, K. et al. Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C. Infect. Immun. 72, 2753–2761 (2004). Revealed that intranasally administered L. lactis that expresses tetanus toxin fragment C elicits a tetanus toxin fragment C-specific T-cell response, which has a mixed profile of T H 1 and T H 2 cytokines in the intestine and a tetanus toxin fragment C-specific IgA response at more than one mucosal site.
  Article CAS PubMed PubMed Central Google Scholar
• Delcenserie, V. et al. Immunomodulatory effects of probiotics in the intestinal tract. Curr. Issues Mol. Biol. 10, 37–54 (2008).
  CAS PubMed Google Scholar
• Steidler, L. et al. Secretion of biologically active murine interleukin-2 by Lactococcus lactis subsp. lactis. Appl. Environ. Microbiol. 61, 1627–1629 (1995).
  CAS PubMed PubMed Central Google Scholar
• Steidler, L. et al. Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect. Immun. 66, 3183–3189 (1998). First demonstration that the secretion of cytokines in L. lactis together with the intracellular production of an antigen can enhance immune responses.
  CAS PubMed PubMed Central Google Scholar
• Bermudez-Humaran, L. G. et al. A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. J. Immunol. 175, 7297–7302 (2005). Demonstrated therapeutic immunization with a recombinant L. lactis cancer vaccine in a mouse model of human papillomavirus type 16-induced tumours.
  Article CAS PubMed Google Scholar
• Cheun, H. I. et al. Protective immunity of SpaA-antigen producing Lactococcus lactis against Erysipelothrix rhusiopathiae infection. J. Appl. Microbiol. 96, 1347–1353 (2004).
  Article CAS PubMed Google Scholar
• Xin, K. Q. et al. Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env. Blood 102, 223–228 (2003).
  Article CAS PubMed Google Scholar
• Corthesy, B., Boris, S., Isler, P., Grangette, C. & Mercenier, A. Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis. J. Infect. Dis. 192, 1441–1449 (2005).
  Article CAS PubMed Google Scholar
• Oliveira, M. L. et al. Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A. Microbes Infect. 8, 1016–1024 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Jechlinger, W. Optimization and delivery of plasmid DNA for vaccination. Expert Rev. Vaccines 5, 803–825 (2006).
  Article CAS PubMed Google Scholar
• Howarth, M. & Elliott, T. The processing of antigens delivered as DNA vaccines. Immunol. Rev. 199, 27–39 (2004).
  Article CAS PubMed Google Scholar
• Guimaraes, V. D. et al. Internalin-expressing Lactococcus lactis is able to invade small intestine of guinea pigs and deliver DNA into mammalian epithelial cells. Microbes Infect. 7, 836–844 (2005). Revealed that L. lactis which expresses an invasin can deliver a DNA-vaccine vector into epithelial cells.
  Article CAS PubMed Google Scholar
• Guimaraes, V. D. et al. Use of native lactococci as vehicles for delivery of DNA into mammalian epithelial cells. Appl. Environ. Microbiol. 72, 7091–7097 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Li, Y. G., Tian, F. L., Gao, F. S., Tang, X. S. & Xia, C. Immune responses generated by Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virus. Vaccine 25, 902–911 (2007).
  Article CAS PubMed Google Scholar
• Steidler, L. et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289, 1352–1355 (2000). Showed that IL-10-secreting lactococci can be used therapeutically in two models of murine colitis.
  Article CAS PubMed Google Scholar
• Steidler, L. In situ delivery of cytokines by genetically engineered Lactococcus lactis. Antonie Van Leeuwenhoek 82, 323–331 (2002).
  Article CAS PubMed Google Scholar
• Schreiber, S. et al. Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's disease IL-10 cooperative study group. Gastroenterology 119, 1461–1472 (2000).
  Article CAS PubMed Google Scholar
• Steidler, L. et al. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nature Biotechnol. 21, 785–789 (2003). Describes the development of a biological-containment system for L. lactis that was based on replacement of the thymidylate synthase gene with a heterologous gene.
  Article CAS Google Scholar
• Vandenbroucke, K. et al. Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterology 127, 502–513 (2004).
  Article CAS PubMed Google Scholar
• Crameri, R. & Rhyner, C. Novel vaccines and adjuvants for allergen-specific immunotherapy. Curr. Opin. Immunol. 18, 761–768 (2006).
  Article CAS PubMed Google Scholar
• Murosaki, S. et al. Heat-killed Lactobacillus plantarum L-137 suppresses naturally fed antigen-specific IgE production by stimulation of IL-12 production in mice. J. Allergy Clin. Immunol. 102, 57–64 (1998).
  Article CAS PubMed Google Scholar
• Kruisselbrink, A., Heijne Den Bak-Glashouwer, M. J., Havenith, C. E., Thole, J. E. & Janssen, R Recombinant Lactobacillus plantarum inhibits house dust mite-specific T-cell responses. Clin. Exp. Immunol. 126, 2–8 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Repa, A. et al. Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine 22, 87–95 (2003).
  Article CAS PubMed Google Scholar
• Chatel, J. M. et al. Characterization of a Lactococcus lactis strain that secretes a major epitope of bovine beta-lactoglobulin and evaluation of its immunogenicity in mice. Appl. Environ. Microbiol. 69, 6620–6627 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Novak, N., Allam, J. P., Betten, H., Haberstok, J. & Bieber, T. The role of antigen presenting cells at distinct anatomic sites: they accelerate and they slow down allergies. Allergy 59, 5–14 (2004).
  Article CAS PubMed Google Scholar
• Adel-Patient, K. et al. Oral administration of recombinant Lactococcus lactis expressing bovine β-lactoglobulin partially prevents mice from sensitization. Clin. Exp. Allergy 35, 539–546 (2005).
  Article CAS PubMed Google Scholar
• Daniel, C. et al. Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1. Allergy 61, 812–819 (2006).
  Article CAS PubMed Google Scholar
• Daniel, C., Repa, A., Mercenier, A., Wiedermann, U. & Wells, J. The European LABDEL project and its relevance to the prevention and treatment of allergies. Allergy 62, 1237–1242 (2007).
  Article CAS PubMed Google Scholar
• Charng, Y. C., Lin, C. C. & Hsu, C. H. Inhibition of allergen-induced airway inflammation and hyperreactivity by recombinant lactic-acid bacteria. Vaccine 24, 5931–5936 (2006).
  Article CAS PubMed Google Scholar
• Huibregtse, I. L. et al. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin. Gastroenterology 133, 517–528 (2007).
  Article CAS PubMed Google Scholar
• Wu, C. et al. Immunomodulatory effects of IL-12 secreted by Lactococcus lactis on Th1/Th2 balance in ovalbumin (OVA)-induced asthma model mice. Int. Immunopharmacol. 6, 610–615 (2006).
  Article CAS PubMed Google Scholar
• Boyd, M. R. et al. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob. Agents Chemother. 41, 1521–1530 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Giomarelli, B. et al. The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1. Aids 16, 1351–1356 (2002).
  Article CAS PubMed Google Scholar
• Pusch, O. et al. Bioengineering lactic acid bacteria to secrete the HIV-1 virucide cyanovirin. J. Acquir. Immune Defic. Syndr. 40, 512–520 (2005). L. lactis that secretes cyanovirin was shown to block HIV-1 infection in vitro.
  Article CAS PubMed Google Scholar
• Liu, X. et al. Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N. Antimicrob. Agents Chemother. 50, 3250–3259 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Chang, T. L. et al. Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4. Proc. Natl Acad. Sci. USA 100, 11672–11677 (2003). Demonstrated that LAB can produce a CD4 receptor that can bind HIV-1 in vitro.
  Article CAS PubMed PubMed Central Google Scholar
• Chancey, C. J. et al. Lactobacilli-expressed single-chain variable fragment (scFv) specific for intercellular adhesion molecule 1 (ICAM-1) blocks cell-associated HIV-1 transmission across a cervical epithelial monolayer. J. Immunol. 176, 5627–5636 (2006).
  Article CAS PubMed Google Scholar
• Rao, S. et al. Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide. Proc. Natl Acad. Sci. USA 102, 11993–11998 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Pusch, O. et al. An anti-HIV microbicide engineered in commensal bacteria: secretion of HIV-1 fusion inhibitors by lactobacilli. Aids 20, 1917–1922 (2006).
  Article CAS PubMed Google Scholar
• Falagas, M. E., Betsi, G. I. & Athanasiou, S. Probiotics for the treatment of women with bacterial vaginosis. Clin. Microbiol. Infect. 13, 657–664 (2007).
  Article CAS PubMed Google Scholar
• Chakraborty, H. et al. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. Aids 15, 621–627 (2001).
  Article CAS PubMed Google Scholar
• Beninati, C. et al. Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria. Nature Biotechnol. 18, 1060–1064 (2000). First example of LAB delivery of a microbicidal antibody and its use for the treatment of candidiasis in a rat model.
  Article CAS Google Scholar
• Kruger, C. et al. In situ delivery of passive immunity by lactobacilli producing single-chain antibodies. Nature Biotechnol. 20, 702–706 (2002). Demonstrated passive immunotherapy against dental caries by blocking the adhesion of S. mutans with LAB that express an scFv.
  Article CAS Google Scholar
• Oliveira, M. L., Areas, A. P. & Ho, P. L. Intranasal vaccines for protection against respiratory and systemic bacterial infections. Expert Rev. Vaccines 6, 419–429 (2007).
  Article CAS PubMed Google Scholar
• Baumann, U., Gocke, K., Gewecke, B., Freihorst, J. & von Specht, B. U. Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study. Respir. Res. 8, 57 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• DiGiandomenico, A. et al. Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections. Proc. Natl Acad. Sci. USA 104, 4624–4629 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Drouault, S., Juste, C., Marteau, P., Renault, P. & Corthier, G. Oral treatment with Lactococcus lactis expressing Staphylococcus hyicus lipase enhances lipid digestion in pigs with induced pancreatic insufficiency. Appl. Environ. Microbiol. 68, 3166–3168 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Han, W. et al. Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase. Inflamm. Bowel Dis. 12, 1044–1052 (2006).
  Article PubMed Google Scholar
• Salminen, S. et al. Demonstration of safety of probiotics — a review. Int. J. Food Microbiol. 44, 93–106 (1998).
  Article CAS PubMed Google Scholar
• Ishibashi, N. & Yamazaki, S. Probiotics and safety. Am. J. Clin. Nutr. 73, (Suppl. 2) 465–470 (2001).
  Article Google Scholar
• Frey, J. Biological safety concepts of genetically modified live bacterial vaccines. Vaccine 25, 5598–5605 (2007).
  Article CAS PubMed Google Scholar
• Perez-Alvarez, L. et al. Long-term monitoring of genotypic and phenotypic resistance to T20 in treated patients infected with HIV-1. J. Med. Virol. 78, 141–147 (2006).
  Article CAS PubMed Google Scholar
• Lee, S. F. Oral colonization and immune responses to Streptococcus gordonii: potential use as a vector to induce antibodies against respiratory pathogens. Curr. Opin. Infect. Dis. 16, 231–235 (2003).
  Article CAS PubMed Google Scholar
• Wells, J. M., Wilson, P. W., Norton, P. M., Gasson, M. J. & Le Page, R. W. Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge. Mol. Microbiol. 8, 1155–1162 (1993).
  Article CAS PubMed Google Scholar
• Chu, H. et al. Lactobacillus acidophilus expressing recombinant K99 adhesive fimbriae has an inhibitory effect on adhesion of enterotoxigenic Escherichia coli. Microbiol. Immunol. 49, 941–948 (2005).
  Article CAS PubMed Google Scholar
• Lee, J. S. et al. Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice. J. Virol. 80, 4079–4087 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Perez, C. A., Eichwald, C., Burrone, O. & Mendoza, D. Rotavirus vp7 antigen produced by Lactococcus lactis induces neutralizing antibodies in mice. J. Appl. Microbiol. 99, 1158–1164 (2005).
  Article CAS PubMed Google Scholar
• Buccato, S. et al. Use of Lactococcus lactis expressing pili from group B Streptococcus as a broad-coverage vaccine against streptococcal disease. J. Infect. Dis. 194, 331–340 (2006).
  Article CAS PubMed Google Scholar
• Pontes, D. S. et al. Induction of partial protection in mice after oral administration of Lactococcus lactis producing Brucella abortus L7/L12 antigen. J. Drug Target. 11, 489–493 (2003).
  Article CAS PubMed Google Scholar
• Poo, H. et al. Oral administration of human papillomavirus type 16 E7 displayed on Lactobacillus casei induces E7-specific antitumor effects in C57/BL6 mice. Int. J. Cancer 119, 1702–1709 (2006).
  Article CAS PubMed Google Scholar
• Zhang, Z. H., Jiang, P. H., Li, N. J., Shi, M. & Huang, W. Oral vaccination of mice against rodent malaria with recombinant Lactococcus lactis expressing MSP-119 . World J. Gastroenterol. 11, 6975–6980 (2005).
  Article CAS PubMed PubMed Central Google Scholar